ADMA Biologics, Inc. Accounts Payable for the year ending December 31, 2024: USD 20.22 M

ADMA Biologics, Inc. Accounts Payable is USD 20.22 M for the year ending December 31, 2024. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.
  • ADMA Biologics, Inc. Accounts Payable for the year ending December 31, 2022 was USD 13.23 M.
  • ADMA Biologics, Inc. Accounts Payable for the year ending December 31, 2020 was USD 11.07 M, a 20.70% change year over year.
Key Data
Date Accounts Payable Short-Term Debt Long-Term Debt Total Liabilities